SEC Form 4 · accession 0000899243-18-001093
MyoKardia Inc · MYOK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Anastasios Gianakakos
Officer — President and CEO · Director
Period of report
Jan 12, 2018
Accepted (ET)
Jan 16, 2018 · 6:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001552451
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 12, 2018 | M | 5,000 | $1.5068 | A | 514,117 | D | |
| Common Stock | Jan 12, 2018 | S | 5,000 | $50.00 | D | 509,117 | D | |
| Common Stock | holding | — | — | — | 181,169 | I | By Reporting Person's Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $1.5068 | Jan 12, 2018 | M | 5,000 | D | — | Jun 3, 2025 | Common Stock | 5,000 | 146,912 | D |
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- F225% of the shares subject to the option vested and became exercisable on June 4, 2016, and the remaining shares subject to this option vest and become exercisable in monthly installments through June 4, 2019.